| [1] |
LU Juping, HU Jun, DENG Yongming, LIAO Shufang.
Downregulation of FKBP4 inhibits the malignant progression of non-small cell lung cancer by blocking the PI3K/Akt/mTOR signaling pathway
[J]. Journal of Practical Oncology, 2025, 39(3): 184-190.
|
| [2] |
LI Caizheng, ZHENG Jing, SU Qiaoli.
Advance progress in immunotherapy for unresectable locally advanced non-small cell lung cancer
[J]. Journal of Practical Oncology, 2025, 39(1): 67-72.
|
| [3] |
CHEN Xingyan, LI Xue, FU Qiang.
Research progress of RNA methylation in lung cancer
[J]. Journal of Practical Oncology, 2024, 38(6): 421-426.
|
| [4] |
HAO Huiting, ZHAO Huijuan, XU Qiaohui.
Expression and clinical significance of hypermethylated in cancer 1 in non-small cell lung cancer
[J]. Journal of Practical Oncology, 2024, 38(5): 306-312.
|
| [5] |
XU Lingyan, LI Qianni, LI Jian, YAO Xuepei, LIU Meina.
Analysis for the impact of the first hospitalization days on treatment quality in patients with non-small cell lung cancer
[J]. Journal of Practical Oncology, 2024, 38(4): 221-226.
|
| [6] |
YAO Xuepei, BAI Shanqi, LIU Meina.
Analysis of factors influencing treatment quality of non-small cell lung cancer based on causal diagram model
[J]. Journal of Practical Oncology, 2024, 38(4): 227-234.
|
| [7] |
MA Na, LIU Jie.
Analysis of lung cancer incidence and mortality in Hedong district,Tianjin,from 2015 to 2020
[J]. Journal of Practical Oncology, 2024, 38(4): 241-245.
|
| [8] |
CHENG Yongming, DONG Huanhuan, XU Hui.
Hsa-let-7b-5p inhibits proliferation,migration and invasion in non-small cell lung cancer
[J]. Journal of Practical Oncology, 2024, 38(3): 157-167.
|
| [9] |
WANG Wenbo, BAI Haixin, ZHANG Tan, NIU Li.
Propofol inhibits glycolysis and tumor progression in lung cancer through GLUT4
[J]. Journal of Practical Oncology, 2024, 38(2): 104-111.
|
| [10] |
BO Yun, HANG Wenlu, ZUO Shurun, Dong Yuan, LI Haiquan.
Effects of long non-coding RNA OTUD6B-AS1 on proliferation,invasion and migration of lung adenocarcinoma A549 cells
[J]. Journal of Practical Oncology, 2024, 38(1): 13-17.
|
| [11] |
ZHANG Xuan, LI Xin, ZHAO Kang.
Relationship between serum inflammatory markers and prognosis of advanced non-small cell lung cancer patients treated with first-line immunosuppressants
[J]. Journal of Practical Oncology, 2024, 38(1): 37-44.
|
| [12] |
CAO Yingyue, PANG Luyi, ZHANG Jian, JIN Shi.
The role of cancer-associated fibroblasts in the progression of non-small cell lung cancer
[J]. Journal of Practical Oncology, 2023, 37(4): 383-388.
|
| [13] |
CHEN Qi, HE Mingxv, JIA Keliang, MIAO Jianlong, HAN Liping.
Research progress on the prognosis and treatment of non-small cell lung cancer with TP53-EGFR co-mutation
[J]. Journal of Practical Oncology, 2023, 37(3): 262-266.
|
| [14] |
XU Zihan, YU Guohua, NIE Yuhui, SUN Mengmeng, FENG Hui, LIU Shuzhen.
Predictive effect of peripheral blood markers on immune-related adverse reactions of advanced non-small cell lung cancer and their correlation with survival outcome
[J]. Journal of Practical Oncology, 2022, 36(6): 544-550.
|
| [15] |
CHEN Junhui, LIU Siyu, HE Changjun.
Research progress of RUNX1 in lung cancer
[J]. Journal of Practical Oncology, 2022, 36(6): 576-579.
|
